Kaitlyn Beyfuss

858 citations
31 papers · 622 indexed · h-index 14
Topics
Pancreatic and Hepatic Oncology Research (11 papers)Neuroendocrine Tumor Research Advances (6 papers)Hepatocellular Carcinoma Treatment and Prognosis (5 papers)

In The Last Decade

Kaitlyn Beyfuss

30 papers receiving 619 citations

Peers

Kaitlyn Beyfuss
Comparison fields: 5 of 99
  • Molecular Biology 182
  • Oncology 158
  • Surgery 141
  • Physiology 131
  • Epidemiology 129
Replace Masaki Imanishi with:
Masaki Imanishi Japan
Hee Young Kim South Korea
Arkadiusz Niklas Poland
Sean Heffron United States
J. C. Smith United Kingdom
M D Barber United Kingdom
Chung Hee Baek South Korea
Miao Yang China
Ruth Schübel Germany
Kaitlyn Beyfuss relative to Masaki Imanishi Japan Masaki Imanishi's profile →
Citations per field
00.5×1.5×2.4×
Masaki Imanishi · 1×
Citations per year

Countries citing papers authored by Kaitlyn Beyfuss

Since Specialization
Citations

This map shows the geographic impact of Kaitlyn Beyfuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaitlyn Beyfuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaitlyn Beyfuss more than expected).

Fields of papers citing papers by Kaitlyn Beyfuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaitlyn Beyfuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaitlyn Beyfuss. The network helps show where Kaitlyn Beyfuss may publish in the future.

Co-authorship network of co-authors of Kaitlyn Beyfuss

This figure shows the co-authorship network connecting the top 25 collaborators of Kaitlyn Beyfuss. A scholar is included among the top collaborators of Kaitlyn Beyfuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaitlyn Beyfuss. Kaitlyn Beyfuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 5
3 17
4 4
5 1
6 21
7 4
8 23
9 13
10 9
11 1
12 27
13 83
14 40
15 33
16 6
17 21
18 39
19 37
20 18

About Kaitlyn Beyfuss

Kaitlyn Beyfuss is a scholar working on Hepatology, Oncology and Cancer Research, having authored 31 papers that have together received 622 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Internal Medicine (22 citations), Oncology (158 citations) and Physiology (131 citations). Kaitlyn Beyfuss has collaborated with scholars based in Canada, France and United States. Frequent co-authors include David A. Hood, Avigail T. Erlich, Julie Hallet, Natalie G. Coburn, Calvin Law, Alyson Mahar, Paul J. Karanicolas, Matthew Triolo, Vanessa N. Palter and Sten Myrehaug. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgery and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026